Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Toshiko Nakai has a total of 152 co-authors. Here are the top co-authors by number of shared publications:

  • Ichiro Watanabe

    Division of Cardiology, Department of Medicine, Nihon University School of Medicine

    48 shared publications
  • Kimie Ohkubo

    Division of Cardiology, Department of Medicine Nihon University School of Medicine Tokyo Japan

    39 shared publications
  • Koichi Nagashima

    Division of Cardiology, Department of Medicine Nihon University School of Medicine Tokyo Japan

    39 shared publications
  • Kazumasa Sonoda

    Tokyo Rinkai Hospital, Division of Cardiology, Department of Medicine

    25 shared publications
  • Satoshi Kunimoto

    Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Japan

    25 shared publications
  • Rikitake Kogawa

    Division of Cardiology, Department of Medicine Nihon University School of Medicine Tokyo Japan

    23 shared publications

Latest Publications

  • Open Access

    Regular Aerobic Exercise and Masticatory Difficulties in Japanese Adults: A Cross-Sectional Study of Potential Systemic Inflammatory Pathways

    by Shigemasa Tani, Yasuyuki Suzuki, Tsukasa Yagi, Atsuhiko Takahashi, Toshiko Nakai

    Objective: Regular physical activity is a key modifiable behavior for disease prevention and healthy aging, but its association with oral functional outcomes remains unclear. We examined the association between regular aerobic exercise and masticatory difficulties and explored potential indirect associations through systemic inflammatory markers.,Methods: This cross-sectional study included 8,251 Japanese adults who underwent annual health examinations in Tokyo, Japan, between April 2024 and April 2025. Regular aerobic exercise and masticatory difficulties were assessed using standardized questionnaires. Multivariable logistic regression and exploratory mediation analyses were performed, adjusting for age, sex, body mass index, diabetes mellitus, alcohol consumption, and current smoking.,Results: Among 8,251 participants, 2,251 (27.3%) reported regular aerobic exercise and 733 (8.9%) reported masticatory difficulties. Regular aerobic exercise was associated with lower odds of masticatory difficulties (OR, 0.83; 95% CI, 0.69–0.99). Significant indirect effects were observed through total white blood cell count (-0.0128; 95% bootstrap CI, -0.0249 to -0.0030) and monocyte count (-0.0127; 95% bootstrap CI, -0.0247 to -0.0039).,Conclusions: Regular aerobic exercise was associated with lower odds of masticatory difficulties. Systemic inflammatory status may accompany this association. Prospective studies are needed to establish temporality and clarify underlying mechanisms.

  • Open Access

    Bradycardia‐Dependent Elevation of Atrial Pacing Threshold Mimicking Lead Failure Early After Pacemaker Implantation

    by Ayano Shibata, Rikitake Kogawa, Yukitoshi Ikeya, Toshiko Nakai, Yasuo Okumura

  • Open Access

    Role of Implantable Cardioverter Defibrillators in Patients With Heart Failure and Nonischemic Cardiomyopathy in Japan ― Analysis From the Nippon Storm Study ―

    by Toshiko Nakai

    Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.

  • Abstract 15220: The Thermal Characteristics to Phrenic and Esophageal Injuries During Ablation of QDOTMICRO (50w-Qmode and 90w/4sec-Qmode+) vs 50w-TactiCath SE vs 50w-Thermocool Smart Touch: Findings From an In-Vivo Porcine Study

    by Naoto Otsuka, Yasuo Okumura, Koichi Nagashima, Sayaka Kurokawa, Ryuta Watanabe, Wakamatsu Yuji, Shu Hirata, Moyuru Hirata, Masanaru Sawada, Toshiko Nakai

  • Characteristics of tissue temperature during ablation with THERMOCOOL SMARTTOUCH SF versus TactiCath versus QDOT MICRO catheters (Qmode and Qmode+): An in vivo porcine study

    by Naoto Otsuka, Yasuo Okumura, Sayaka Kuorkawa, Koichi Nagashima, Yuji Wakamatsu, Satoshi Hayashida, Kimie Ohkubo, Toshiko Nakai, Rie Takahashi, Yoshiki Taniguchi

    Introduction: High‐power short‐duration (HPSD) ablation at 50 W, guided by ablation index (AI) or lesion size index (LSI), and a 90 W/4 s very HSPD (vHPSD) setting are available for atrial fibrillation (AF) treatment. Yet, tissue temperatures during ablation with different catheters around venoatrial junction and collateral tissues remain unclear.Methods: In this porcine study, we surgically implanted thermocouples on the epicardium near the superior vena cava (SVC), right pulmonary vein, and esophagus close to the inferior vena cava. We then compared tissue temperatures during 50W‐HPSD guided by AI 400 or LSI 5.0, and 90 W/4 s‐vHPSD ablation using THERMOCOOL SMARTTOUCH SF (STSF), TactiCath ablation catheter, sensor enabled (TacthCath), and QDOT MICRO (Qmode and Qmode+ settings) catheters.Results: STSF produced the highest maximum tissue temperature (Tmax), followed by TactiCath, and QDOT MICRO in Qmode and Qmode+ (62.7 ± 12.5°C, 58.0 ± 10.1°C, 50.0 ± 12.1°C, and 49.2 ± 8.4°C, respectively; p = .005), achieving effective transmural lesions. Time to lethal tissue temperature ≥50°C (t−T ≥ 50°C) was fastest in Qmode+, followed by TacthCath, STSF, and Qmode (4.3 ± 2.5, 6.4 ± 1.9, 7.1 ± 2.8, and 7.7 ± 3.1 s, respectively; p < .001). The catheter tip‐to‐thermocouple distance for lethal temperature (indicating lesion depth) from receiver operating characteristic curve analysis was deepest in STSF at 5.2 mm, followed by Qmode at 4.3 mm, Qmode+ at 3.1 mm, and TactiCath at 2.8 mm. Ablation at the SVC near the phrenic nerve led to sudden injury at t−T ≥ 50°C in all four settings. The esophageal adventitia injury was least deep with Qmode+ ablation (0.4 ± 0.1 vs. 0.8 ± 0.4 mm for Qmode, 0.9 ± 0.3 mm for TactiCath, and 1.1 ± 0.5 mm for STSF, respectively; p = .005), correlating with Tmax.Conclusion: This study revealed distinct tissue temperature patterns during HSPD and vHPSD ablations with the three catheters, affecting lesion effectiveness and collateral damage based on Tmax and/or t−T ≥ 50°C. These findings provide key insights into the safety and efficacy of AF ablation with these four settings.


  • Open Access

    When Is Cardiac Resynchronization Therapy with a Defibrillator Indicated in Patients with Heart Failure, Especially Elderly Patients?

    by Hiroaki Mano, Toshiko Nakai, Yukitoshi Ikeya, Rikitake Kogawa, Yuki Saito, Sayaka Kurokawa, Koichi Nagashima, Yasuo Okumura

    One benefit of an implantable cardioverter-defibrillator is the prevention of sudden cardiac death (SCD). It is recommended for patients with a low left ventricular ejection fraction (LVEF). However, the choice of cardiac resynchronization therapy (CRT) with or without a defibrillator (CRT-D and CRT-P) in elderly patients is controversial. To understand the current situation for proper device selection, we investigated the impact of defibrillators on mortality in elderly patients with heart failure. Consecutive patients who underwent CRT implantation were retrospectively recruited. Baseline characteristics, all-cause mortality, cardiac death, and defibrillator implantation rates were investigated in patients aged > 75 or ≤ 75 years. A total of 285 patients (79 patients aged > 75 years) were analyzed. Elderly patients had more comorbidities, but a lower proportion had ventricular arrhythmia. During the mean follow-up of 47 months, 109 patients died (67 due to cardiac death). Kaplan-Meier analysis showed higher mortality in elderly patients (P = 0.0428) but no significant difference in cardiac death by age group (P = 0.7472). There were no significant differences in mortality between patients with CRT-D versus CRT-P (P = 0.3386). SCD was rare. A defibrillator had no significant impact on mortality. In elderly patients, comorbidities are common and related to mortality. The selection of CRT-D versus CRT-P should take those factors into account.


  • PO-01-033 CAN CATHETER TIP TEMPERATURES INCORPORATED INTO THE QDOT MICRO CATHETER MONITOR ACTUAL TISSUE TEMPERATURES DURING 90W/4SEC-VERY HIGH-POWER SHORT-DURATION (VHPSD) ABLATION AND 50W-HPSD ABLATION?

    by Naoto Otsuka, Yasuo Okumura, Koichi Nagashima, Sayaka Kurokawa, Ryuta Watanabe, Yuji Wakamatsu, Shu Hirata, Moyuru Hirata, Masanaru Sawada, Toshiko Nakai

  • Open Access

    In vivo tissue temperatures during 90 W/4 sec‐very high power‐short‐duration (vHPSD) ablation versus ablation index‐guided 50 W‐HPSD ablation: A porcine study

    by Naoto Otsuka, Yasuo Okumura, Sayaka Kuorkawa, Koichi Nagashima, Yuji Wakamatsu, Satoshi Hayashida, Kimie Ohkubo, Toshiko Nakai, Hiroyuki Hao, Rie Takahashi, et al.

    Introduction: Neither the actual in vivo tissue temperatures reached with 90 W/4 s‐very high‐power short‐duration (vHPSD) ablation for atrial fibrillation nor the safety and efficacy profile have been fully elucidated.Methods: We conducted a porcine study (n = 15) in which, after right thoracotomy, we implanted 6–8 thermocouples epicardially in the superior vena cava, right pulmonary vein, and esophagus close to the inferior vena cava. We compared tissue temperatures close to a QDOT MICRO catheter, between during 90 W/4 s‐vHPSD ablation during ablation index (AI: target 400)‐guided 50 W‐HPSD ablation, both targeting a contact force of 8–15 g.Results: Maximum tissue temperature reached during 90 W/4 s‐vHPSD ablation did not differ significantly from that during 50 W‐HPSD ablation (49.2 ± 8.4°C vs. 50.0 ± 12.1°C; p = .69) and correlated inversely with distance between the catheter tip and the thermocouple, regardless of the power settings (r = −0.52 and r = −0.37). Lethal temperature (≥50°C) was best predicted at a catheter tip‐to‐thermocouple distance cut‐point of 3.13 and 4.27 mm, respectively. All lesions produced by 90 W/4 s‐vHPSD or 50 W‐HPSD ablation were transmural. Although there was no difference in the esophageal injury rate (50% vs. 66%, p = .80), the thermal lesion was significantly shallower with 90 W/4 s‐vHPSD ablation than with 50W‐HPSD ablation (381.3 ± 127.3 vs. 820.0 ± 426.1 μm from the esophageal adventitia; p = .039).Conclusion: Actual tissue temperatures reached with 90 W/4 s‐vHPSD ablation appear similar to those with AI‐guided 50 W‐HPSD ablation, with the distance between the catheter tip and target tissue being shorter for the former. Although both ablation settings may create transmural lesions in thin atrial tissues, any resulting esophageal thermal lesions appear shallower with 90 W/4 s‐vHPSD ablation.


  • In vivo tissue temperature during lesion size index‐guided 50W ablation versus 30W ablation: A porcine study

    by Naoto Otsuka, Yasuo Okumura, Sayaka Kuorkawa, Koichi Nagashima, Yuji Wakamatsu, Satoshi Hayashida, Kimie Ohkubo, Toshiko Nakai, Hiroyuki Hao, Rie Takahashi, et al.

    Background: Neither the actual in vivo tissue temperatures reached with lesion size index (LSI)‐guided high‐power short‐duration (HPSD) ablation for atrial fibrillation nor the safety profile has been elucidated.Methods: We conducted a porcine study (n = 7) in which, after right thoracotomy, we implanted 6–8 thermocouples epicardially in the superior vena cava, right pulmonary vein, and esophagus close to the inferior vena cava. We compared tissue temperatures reached during 50 W‐HPSD ablation with those reached during standard (30 W) ablation, both targeting an LSI of 5.0 (5–15 g contact force).Results: Tmax (maximum tissue temperature when the thermocouple was located ≤5 mm from the catheter tip) reached during HPSD ablation was modestly higher than that reached during standard ablation (58.0 ± 10.1°C vs. 53.6 ± 9.2°C; p = .14) and peak tissue temperature correlated inversely with the distance between the catheter tip and the thermocouple, regardless of the power settings (HPSD: r = −0.63; standard: r = −0.66). Lethal temperature (≥50°C) reached 6.3 ± 1.8 s and 16.9 ± 16.1 s after the start of HPSD and standard ablation, respectively (p = .002), and it was best predicted at a catheter tip‐to‐thermocouple distance cut point of 2.8 and 5.3 mm, respectively. All lesions produced by HPSD ablation and by standard ablation were transmural. There was no difference between HPSD ablation and standard ablation in the esophageal injury rate (70% vs. 75%, p = .81), but the maximum distance from the esophageal adventitia to the injury site tended to be shorter (0.94 ± 0.29 mm vs. 1.40 ± 0.57 mm, respectively; p = .09).Conclusions: Actual tissue temperatures reached with LSI‐guided HPSD ablation appear to be modestly higher, with a shorter distance between the catheter tip and thermocouple achieving lethal temperature, than those reached with standard ablation. HPSD ablation lasting <6 s may help minimize lethal thermal injury to the esophagus lying at a close distance.


  • Open Access

    Cardiac resynchronization therapy: Current status and near-future prospects

    by Toshiko Nakai, Yukitoshi Ikeya, Rikitake Kogawa, Yasuo Okumura